Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,321.10
-30.50 (-2.26%)
Mar 13, 2026, 3:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 183 billion as of March 13, 2026. Its market cap has increased by 4.76% in one year.
Market Cap
183.00B
Enterprise Value
210.27B
Revenue
30.65B
Ranking
n/a
PE Ratio
41.77
Stock Price
1,321.10
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 183.00B, an increase of 121.27%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 187.23B | -8.71% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 389.16B |
| Ajanta Pharma | 380.68B |
| Emcure Pharmaceuticals | 295.78B |
| Gland Pharma | 274.65B |
| Wockhardt | 212.12B |
| Piramal Pharma | 206.37B |
| NATCO Pharma | 182.00B |
| Alembic Pharmaceuticals | 138.79B |